Charles River Laboratories International, Inc. Common Stock (NY:CRL)
Price and Volume
Detailed Quote| Volume | 1,662,200 |
| Open | 330.14 |
| Bid (Size) | 305.25 (80) |
| Ask (Size) | 340.00 (40) |
| Prev. Close | 326.29 |
| Today's Range | 311.68 - 330.75 |
| 52wk Range | 146.19 - 379.63 |
| Shares Outstanding | 50,396,622 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
17.5% below 52-week high
313.02
146.1952W Low
379.6352W High
1 Week
16.4% below 1-week high
311.681W Low
374.561W High
Charles River Laboratories International, Inc. Common Stock (CRL) traded between $146.19 and $379.63 over the past 52 weeks and last traded at $313.02, 17.5% below its 52-week high. Over the past week it ranged between $311.68 and $374.56.
Past 12 Months
1W
-$46.39
1M
+$8.06
3M
+$47.51
6M
+$131.34
YTD
+$110.60
1Y
+$145.32
CRL was +86.7% over the past year, +72.3% over six months, +54.6% year to date, -12.9% in the last week.
12 Months vs Market
CRL
+86.7%
DIA
+8.7%
SPY
+8.2%
QQQ
+3.8%
IWM
+10.7%
Over the past 12 months CRL returned +86.7% versus DIA (Dow) +8.7%, SPY (S&P 500) +8.2%, QQQ (Nasdaq 100) +3.8% and IWM (Russell 2000) +10.7%.
Volume & Liquidity
1.56× 3-mo avg
Today 1,662,200
3-mo avg 1.1M
1W
1.6M
1M
1.3M
3M
1.1M
6M
989.3K
YTD
967.6K
1Y
954.6K
CRL most recently traded 1,662,200 shares against a 3-month average daily volume of 1.1M.
More News
Read More
Charles River (CRL) Q3 2026 Earnings Call Transcript ↗
November 04, 2026
Charles River Laboratories (NYSE:CRL) exceeds Q3 2026 expectations
November 04, 2026
Charles River Laboratories Announces Third-Quarter 2026 Results
November 04, 2026
What to expect from Charles River Laboratories’s (CRL) Q3 earnings
November 02, 2026
Charles River Leverages Virtual Control Groups in GLP Studies
October 27, 2026
2 healthcare stocks to keep an eye on and 1 that underwhelm
October 23, 2026
3 mid-cap stocks walking a fine line
October 22, 2026
S&P 500 Top Movers: Oct. 21, 2026 US Session ↗
October 21, 2026
S&P 500 Top Movers: Gainers and Losers From Today's US Session ↗
October 20, 2026
1 S&P 500 Stock to Target This Week and 2 We Question
October 12, 2026
Which S&P500 stocks are moving on Monday? ↗
October 05, 2026
Charles River Targets 5%-7% Growth, $300M Savings in 2030 Plan ↗
September 25, 2026
Discover which S&P500 stocks are making waves on Thursday. ↗
September 24, 2026
Why Charles River Laboratories (CRL) Stock Is Up Today
September 24, 2026
Frequently Asked Questions
Is Charles River Laboratories International, Inc. Common Stock publicly traded?
Yes, Charles River Laboratories International, Inc. Common Stock is publicly traded.
What exchange does Charles River Laboratories International, Inc. Common Stock trade on?
Charles River Laboratories International, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Charles River Laboratories International, Inc. Common Stock?
The ticker symbol for Charles River Laboratories International, Inc. Common Stock is CRL on the New York Stock Exchange
What is the current price of Charles River Laboratories International, Inc. Common Stock?
The current price of Charles River Laboratories International, Inc. Common Stock is 313.02
When was Charles River Laboratories International, Inc. Common Stock last traded?
The last trade of Charles River Laboratories International, Inc. Common Stock was at 11/05/26 07:00 PM ET
What is the market capitalization of Charles River Laboratories International, Inc. Common Stock?
The market capitalization of Charles River Laboratories International, Inc. Common Stock is 15.78B
How many shares of Charles River Laboratories International, Inc. Common Stock are outstanding?
Charles River Laboratories International, Inc. Common Stock has 16B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
